Regarding molecular differences, Singhal et al. found that t-MDS patients with ≥15% ringed sideroblasts had a low frequency of SF3B1 mutations, but a much higher frequency of TP53 mutations compared with patients with p-MDS [41]. The gene discussed is SF3B1; the disease is myelodysplastic syndrome.